Embracing Innovation And The Future Of Clinical Studies

By Henry McNamara, Senior Vice President and General Manager, Oracle Health Sciences

There’s no question that the pandemic brought innovation in life sciences.

The industry has been forced to change, adapt, and innovate in unexpected ways, compressing digital transformation roadmaps for how clinical trials are planned and conducted.

Many changes offer lasting, positive impact. But can we maintain and continue this rapid transformation?

At Oracle Health Sciences Connect 2022, the keynote panel (Embrace the Future: Innovation at the Speed of Science) brought together experts to share insights on decentralized trials, direct-to-patient services, technology, and the change process itself:

• How do we increase diversity, reduce enrollment barriers, and simplify the trial experience?
• What role will regulation and technology play, including machine learning and artificial intelligence (AI)?
• How do we advance and optimize new methods of conducting clinical trials and use of real-world data to provide insights?
• What can be done to foster organizational change, and drive change in behaviors, work practices, and workplace culture?

As agents of change, the panelists offered fascinating perspective on the challenges for continued innovation.